Presentation TCT 2022

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

Presenter: Jonas Lanz

September 17, 2022

REGISTER for free or LOG IN to view this content

Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo vs the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

Structural Heart

TCT 2022

Aortic Valve

Up Next

Presentation TCT 2022

Contemporary Clinical and Echocardiographic Outcomes of 1000+ Patients Treated With MitraClip™ G4: Results From the EXPAND G4 Post Approval Study

Presenter: Jason H. RogersRalph Stephan von Bardeleben

September 17, 2022

More slides +

Presentation TCT 2022

The PASCAL IID Registry: A Prospective Registry for Transcatheter Edge-to-Edge Repair in Prohibitive Risk Patients With Degenerative Mitral Regurgitation and Complex Mitral Valve Anatomy

Presenter: Jörg Hausleiter

September 17, 2022

Presentation TCT 2022

Percutaneous or Surgical Management of Post-Infarction Ventricular Septal Defects: The United Kingdom National Registry

Presenter: Joel Peter Giblett

September 17, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.